DRI Healthcare Trust (TSX:DHT.UN)
15.88
-0.02 (-0.13%)
At close: May 12, 2026
DRI Healthcare Trust Revenue
In the year 2025, DRI Healthcare Trust had annual revenue of $191.81M USD with 2.58% growth. DRI Healthcare Trust had revenue of $59.60M in the quarter ending December 31, 2025, a decrease of -3.50%.
Revenue
$191.81M
Revenue Growth
+2.58%
P/S Ratio
3.32
Revenue / Employee
$5.99M
Employees
32
Market Cap
873.67M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 191.81M | 4.83M | 2.58% |
| Dec 31, 2024 | 186.99M | 20.71M | 12.45% |
| Dec 31, 2023 | 166.28M | 73.25M | 78.73% |
| Dec 31, 2022 | 93.03M | 11.27M | 13.78% |
| Dec 31, 2021 | 81.77M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.67B |
| Trulieve Cannabis | 1.63B |
| Verano Holdings | 1.14B |
| Cresco Labs | 895.33M |
| Knight Therapeutics | 510.45M |
| Aurora Cannabis | 373.12M |
| TerrAscend | 365.43M |
| Organigram Global | 279.99M |
DRI Healthcare Trust News
- 2 months ago - DRI Healthcare Trust Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - DRI Healthcare Trust Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - DRI Healthcare Trust Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - DRI Healthcare Trust Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - DRI Healthcare Trust Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - DRI Healthcare Trust Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - DRI Healthcare Trust Earnings Call Transcript: Q2 2024 - Transcripts
- 2 years ago - DRI Healthcare Trust Earnings Call Transcript: Q1 2024 - Transcripts